Results 191 to 200 of about 3,079,233 (343)
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Estimation of state of health for lithium-ion batteries using advanced data-driven techniques. [PDF]
Rout S, Samal SK, Gelmecha DJ, Mishra S.
europepmc +1 more source
Estimation of the State of Charge/Health of Electric Vehicle Batteries Through Machine Learning Approach [PDF]
Capasso Clemente +4 more
openalex +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
Machine Learning-Assisted Prediction of State of Health in Lithium Metal Batteries with Electrochemical Impedance Spectroscopy. [PDF]
Yoon J +7 more
europepmc +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Identification of generic stateofhealth indicators of fuel cell system and tank ...
openaire +1 more source
STUDENT STATE OF HEALTH OF NIZHYN HIGHER SCHOOL (late 19th – 20s of the 20th century) [PDF]
Serhii KYRYLENKO, Oleksii LEIBEROV
openalex +1 more source

